{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:53:16Z","timestamp":1790841196209,"version":"4.1.0"},"reference-count":41,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2016,8,19]],"date-time":"2016-08-19T00:00:00Z","timestamp":1471564800000},"content-version":"vor","delay-in-days":231,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,8,19]],"date-time":"2016-08-19T00:00:00Z","timestamp":1471564800000},"content-version":"vor","delay-in-days":231,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R15AR061722"],"award-info":[{"award-number":["R15AR061722"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. exp. orthop."],"published-print":{"date-parts":[[2016,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Interleukin\u20101 receptor antagonist (IL\u20101 ra) can be disease\u2010modifying in posttraumatic osteoarthritis (PTOA). One limitation is its short joint residence time. We hypothesized that IL\u20101 ra encapsulation in poly (lactide\u2010co\u2010glycolide) (PLGA) microspheres reduces IL\u20101 ra systemic absorption and provides an enhanced anti\u2010PTOA effect.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p><jats:italic>IL\u20101 ra release kinetics and biological activity:<\/jats:italic> IL\u20101 ra encapsulation into PLGA microsphere was performed using double emulsion solvent extraction. Lyophilized PLGA IL\u20101 ra microspheres were resuspended in PBS and supernatant IL\u20101 ra concentrations were assayed. The biological activity of IL\u20101 ra from PLGA IL\u20101 ra microspheres was performed using IL\u20101\u00a0induced lymphocyte proliferation and bovine articular cartilage degradation assays. <jats:italic>Systemic absorption of IL\u20101 ra following intra\u2010articular (IA) injection of PLGA IL\u20101 ra or IL\u20101 ra:<\/jats:italic> At 1, 3, 6, 12 and 24 h following injection of 50 \u03bcl PLGA IL\u20101 ra (<jats:italic>n<\/jats:italic>\u2009=\u20096) or IL\u20101 ra (<jats:italic>n<\/jats:italic>\u2009=\u20096), serum samples were collected and IL\u20101 ra concentrations were determined. <jats:italic>Anterior cruciate ligament<\/jats:italic><jats:italic>transection (ACLT) and IA dosing:<\/jats:italic> ACLT was performed in 8\u201310 week old male Lewis rats (<jats:italic>n<\/jats:italic>\u2009=\u200942). PBS (50 \u03bcl; <jats:italic>n<\/jats:italic>\u2009=\u20099), IL\u20101 ra (50 \u03bcl; 5\u00a0mg\/ml; <jats:italic>n<\/jats:italic>\u2009=\u200913), PLGA IL\u20101 ra (50 \u03bcl; equivalent to 5\u00a0mg\/ml IL\u20101 ra; <jats:italic>n<\/jats:italic>\u2009=\u200914) or PLGA particles (50 \u03bcl; <jats:italic>n<\/jats:italic>\u2009=\u20096) treatments were performed on days 7, 14, 21 and 28 following ACLT. <jats:italic>Cartilage and synovial histopathology:<\/jats:italic> On day 35, animal ACLT joints were harvested and tibial cartilage and synovial histopathology scoring was performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Percent IL\u20101 ra content in the supernatant at 6 h was 13.44\u2009\u00b1\u20099.27 % compared to 34.16\u2009\u00b1\u200912.04 %, 47.89\u2009\u00b1\u200912.71 %, 57.14\u2009\u00b1\u200911.71 %, and 93.90\u2009\u00b1\u20098.50 % at 12, 24, 48 and 72 h, respectively. PLGA IL\u20101 ra inhibited lymphocyte proliferation and cartilage degradation similar to IL\u20101 ra. Serum IL\u20101 ra levels were significantly lower at 1, 3, and 6 h following PLGA IL\u20101 ra injection compared to IL\u20101 ra. Cartilage and synovial histopathology scores were significantly lower in the PLGA IL\u20101 ra group compared to PBS and PLGA groups (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>IL\u20101 ra encapsulation in PLGA microspheres is feasible with no alteration to IL\u20101 ra biological activity. PLGA IL\u20101 ra exhibited an enhanced disease\u2010modifying effect in a PTOA model compared to similarly dosed IL\u20101 ra.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s40634-016-0054-4","type":"journal-article","created":{"date-parts":[[2016,8,18]],"date-time":"2016-08-18T19:40:55Z","timestamp":1471549255000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Intra\u2010articular interleukin\u20101 receptor antagonist (IL1\u2010ra) microspheres for posttraumatic osteoarthritis: in vitro biological activity and in vivo disease modifying effect"],"prefix":"10.1002","volume":"3","author":[{"given":"Khaled A.","family":"Elsaid","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences School of Pharmacy\u2010Boston MCPHS University Boston MA USA"},{"name":"Biomedical and Pharmaceutical Sciences Chapman University School of Pharmacy 9401\u00a0Jeronimo Road 92618 Irvine CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Ubhe","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences School of Pharmacy\u2010Boston MCPHS University Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyad","family":"Shaman","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences School of Pharmacy\u2010Boston MCPHS University Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"D\u2019Souza","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences School of Pharmacy\u2010Boston MCPHS University Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,8,19]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01552652"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar3216"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23495"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00264\u2010005\u20100023\u20105"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0968\u20100160(02)00083\u20102"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/jor.21309"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390914"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24096"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar3430"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102125.1994.tb04365.x"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248\u2010011\u20109315\u20104"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2015.03.017"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2014.01.005"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2013.159"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2012.08.006"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2004.09.010"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/bit.24431"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2008.04.042"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2014.11.010"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.030759"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.b.31822"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2012.07.021"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/02652040801999551"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22952"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022\u20101759(90)90252\u2010Q"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/978\u20101\u201059745\u2010401\u20108_12"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2005.07.014"},{"issue":"4","key":"e_1_2_10_29_1","first-page":"561","article-title":"Synovial pathology in an ovine model of osteoarthritis: effect of intraarticular hyaluronan (Hyalgan)","volume":"26","author":"Cake MA","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2008.12.017"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2701"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2007.07.015"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar3932"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026498209874"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2012.04.021"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.33461"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2014.09.006"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S8756\u20103282(01)00504\u2010X"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e32830aba34"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2012.02.012"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2012.08.027"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar4591"}],"container-title":["Journal of Experimental Orthopaedics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40634-016-0054-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40634-016-0054-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/esskajournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1186\/s40634-016-0054-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40634-016-0054-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T18:43:20Z","timestamp":1760640200000},"score":1,"resource":{"primary":{"URL":"https:\/\/esskajournals.onlinelibrary.wiley.com\/doi\/10.1186\/s40634-016-0054-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.1186\/s40634-016-0054-4"],"URL":"https:\/\/doi.org\/10.1186\/s40634-016-0054-4","archive":["Portico"],"relation":{},"ISSN":["2197-1153","2197-1153"],"issn-type":[{"value":"2197-1153","type":"print"},{"value":"2197-1153","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"7 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"18"}}